speb/financial-data huggingface dataset:
DRX.AX cash_flow (annual, 2022-12-31) — Free Cash Flow: -9570925.00
DRX.AX income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 68909.00
DRX.AX balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 559089.00
DRX.AX income_statement (annual, 2022-12-31) — General And Administrative Expense: 2930269.00
DRX.AX balance_sheet (annual, 2022-12-31) — Gross PPE: 16771596.00
DRX.AX income_statement (annual, 2022-12-31) — Gross Profit: 697.00
DRX.AX income_statement (annual, 2022-12-31) — Interest Expense: 120972.00
DRX.AX income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 120972.00
DRX.AX income_statement (annual, 2022-12-31) — Interest Income: 93816.00
DRX.AX income_statement (annual, 2022-12-31) — Interest Income Non Operating: 93816.00
DRX.AX cash_flow (annual, 2022-12-31) — Interest Paid Direct: -124243.00
DRX.AX cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 124243.00
DRX.AX cash_flow (annual, 2022-12-31) — Interest Received Direct: 26008.00
DRX.AX balance_sheet (annual, 2022-12-31) — Invested Capital: 54255682.00
DRX.AX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -6954807.00
DRX.AX balance_sheet (annual, 2022-12-31) — Investments And Advances: 25142484.00
DRX.AX balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 25117484.00
DRX.AX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 17756384.00
DRX.AX balance_sheet (annual, 2022-12-31) — Long Term Debt: 1509375.00
DRX.AX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1509375.00
DRX.AX balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 25117484.00
DRX.AX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1320493.00
DRX.AX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 16667250.00
DRX.AX income_statement (annual, 2022-12-31) — Net Income: 4978378.00
DRX.AX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 4978378.00
DRX.AX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 4978378.00
DRX.AX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 4978378.00
DRX.AX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 4978378.00
DRX.AX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 4978378.00
DRX.AX income_statement (annual, 2022-12-31) — Net Interest Income: -27156.00
DRX.AX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -27156.00
DRX.AX cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -126714.00
DRX.AX balance_sheet (annual, 2022-12-31) — Net PPE: 15974118.00
DRX.AX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -371797.00
DRX.AX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 52746307.00
DRX.AX balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 70136.00
DRX.AX income_statement (annual, 2022-12-31) — Normalized EBITDA: 5201719.00
DRX.AX income_statement (annual, 2022-12-31) — Normalized Income: 4909469.00
DRX.AX income_statement (annual, 2022-12-31) — Operating Income: -3292662.00
DRX.AX income_statement (annual, 2022-12-31) — Operating Revenue: 697.00
DRX.AX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 3729759126.00
DRX.AX balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 559089.00
DRX.AX income_statement (annual, 2022-12-31) — Other Gand A: 1359641.00
DRX.AX income_statement (annual, 2022-12-31) — Other Income Expense: 8298196.00
DRX.AX balance_sheet (annual, 2022-12-31) — Other Investments: 25000.00
DRX.AX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 13365.00
DRX.AX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 8229287.00
DRX.AX income_statement (annual, 2022-12-31) — Other Operating Expenses: 191115.00
DRX.AX balance_sheet (annual, 2022-12-31) — Other Payable: 385214.00
DRX.AX balance_sheet (annual, 2022-12-31) — Other Properties: 15451103.00
DRX.AX balance_sheet (annual, 2022-12-31) — Other Receivables: 122073.00
DRX.AX balance_sheet (annual, 2022-12-31) — Payables: 967303.00
DRX.AX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 967303.00
DRX.AX cash_flow (annual, 2022-12-31) — Paymentsto Suppliersfor Goodsand Services: -2426947.00
DRX.AX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 8950.00
DRX.AX income_statement (annual, 2022-12-31) — Pretax Income: 4978378.00
DRX.AX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -479751.00
DRX.AX cash_flow (annual, 2022-12-31) — Receiptsfrom Customers: 17018.00
DRX.AX balance_sheet (annual, 2022-12-31) — Receivables: 562984.00
DRX.AX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 171278.00
DRX.AX income_statement (annual, 2022-12-31) — Rent And Landing Fees: 27260.00
DRX.AX cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -1089134.00
DRX.AX balance_sheet (annual, 2022-12-31) — Retained Earnings: -41450397.00
DRX.AX income_statement (annual, 2022-12-31) — Salaries And Wages: 1543368.00
DRX.AX cash_flow (annual, 2022-12-31) — Sale Of PPE: 107954.00
DRX.AX income_statement (annual, 2022-12-31) — Selling General And Administration: 2930269.00
DRX.AX balance_sheet (annual, 2022-12-31) — Share Issued: 3729759126.00
DRX.AX income_statement (annual, 2022-12-31) — Special Income Charges: 68909.00
DRX.AX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 52746307.00
DRX.AX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 52746307.00
DRX.AX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
DRX.AX income_statement (annual, 2022-12-31) — Tax Provision: 0.00
DRX.AX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
DRX.AX balance_sheet (annual, 2022-12-31) — Total Assets: 55333890.00
DRX.AX balance_sheet (annual, 2022-12-31) — Total Capitalization: 54255682.00
DRX.AX balance_sheet (annual, 2022-12-31) — Total Debt: 1541194.00
DRX.AX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 52746307.00
DRX.AX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2587583.00
DRX.AX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 41129967.00
DRX.AX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1579511.00
DRX.AX income_statement (annual, 2022-12-31) — Total Unusual Items: 68909.00
DRX.AX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 68909.00
DRX.AX balance_sheet (annual, 2022-12-31) — Working Capital: 13195851.00
DRX.AX income_statement (annual, 2023-12-31) — +Operating Expense: 3808296.00
DRX.AX balance_sheet (annual, 2023-12-31) — Accounts Payable: 313914.00
DRX.AX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 168062.00
DRX.AX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -872899.00
DRX.AX income_statement (annual, 2023-12-31) — Basic Average Shares: 3729759126.00
DRX.AX income_statement (annual, 2023-12-31) — Basic EPS: 0.00
DRX.AX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 13640939.00
DRX.AX cash_flow (annual, 2023-12-31) — Capital Expenditure: -483388.00
DRX.AX cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -193706.00
DRX.AX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 221316.00
DRX.AX balance_sheet (annual, 2023-12-31) — Capital Stock: 93637615.00
DRX.AX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 10772458.00
DRX.AX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 10772458.00
DRX.AX balance_sheet (annual, 2023-12-31) — Cash Equivalents: 9000000.00
DRX.AX balance_sheet (annual, 2023-12-31) — Cash Financial: 1772458.00
DRX.AX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -86472.00
DRX.AX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -462488.00
DRX.AX cash_flow (annual, 2023-12-31) — Cash Flowsfromusedin Operating Activities Direct: -2319521.00
DRX.AX cash_flow (annual, 2023-12-31) — Changes In Cash: -2868481.00
DRX.AX cash_flow (annual, 2023-12-31) — Classesof Cash Payments: -2645027.00
DRX.AX cash_flow (annual, 2023-12-31) — Classesof Cash Receiptsfrom Operating Activities: 7890.00
DRX.AX balance_sheet (annual, 2023-12-31) — Common Stock: 93637615.00
DRX.AX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 63570778.00
DRX.AX balance_sheet (annual, 2023-12-31) — Current Assets: 11086189.00
DRX.AX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 95957.00
DRX.AX balance_sheet (annual, 2023-12-31) — Current Debt: 1525313.00
DRX.AX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1621270.00
DRX.AX balance_sheet (annual, 2023-12-31) — Current Liabilities: 2768191.00
DRX.AX income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 214220.00
DRX.AX income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 214220.00
DRX.AX income_statement (annual, 2023-12-31) — Depreciation Income Statement: 214220.00
DRX.AX income_statement (annual, 2023-12-31) — Diluted Average Shares: 3729759126.00
DRX.AX income_statement (annual, 2023-12-31) — Diluted EPS: 0.00
DRX.AX income_statement (annual, 2023-12-31) — EBIT: 10496098.00
DRX.AX income_statement (annual, 2023-12-31) — EBITDA: 10710318.00
DRX.AX income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 12010.00
DRX.AX balance_sheet (annual, 2023-12-31) — Employee Benefits: 67567.00
DRX.AX cash_flow (annual, 2023-12-31) — End Cash Position: 10772458.00
DRX.AX cash_flow (annual, 2023-12-31) — Financing Cash Flow: -86472.00
DRX.AX cash_flow (annual, 2023-12-31) — Free Cash Flow: -2802909.00
DRX.AX income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 17245.00
DRX.AX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 1017351.00
DRX.AX income_statement (annual, 2023-12-31) — General And Administrative Expense: 3272855.00
DRX.AX balance_sheet (annual, 2023-12-31) — Gross PPE: 17323003.00
DRX.AX income_statement (annual, 2023-12-31) — Interest Expense: 129889.00
DRX.AX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 129889.00
DRX.AX income_statement (annual, 2023-12-31) — Interest Income: 448606.00
DRX.AX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 448606.00
DRX.AX cash_flow (annual, 2023-12-31) — Interest Paid Direct: -102850.00
DRX.AX cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 102850.00
DRX.AX cash_flow (annual, 2023-12-31) — Interest Received Direct: 420466.00
DRX.AX balance_sheet (annual, 2023-12-31) — Invested Capital: 65096091.00
DRX.AX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -462488.00
DRX.AX balance_sheet (annual, 2023-12-31) — Investments And Advances: 38973137.00
DRX.AX balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 38948137.00
DRX.AX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 125359.00
DRX.AX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 125359.00
DRX.AX balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 38948137.00
DRX.AX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1327474.00
DRX.AX income_statement (annual, 2023-12-31) — Net Income: 10366209.00
DRX.AX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 10366209.00
DRX.AX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 10366209.00
DRX.AX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 10366209.00
DRX.AX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 10366209.00
DRX.AX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 10366209.00
DRX.AX income_statement (annual, 2023-12-31) — Net Interest Income: 318717.00
DRX.AX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -9100.00
DRX.AX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 318717.00
DRX.AX cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -172944.00
DRX.AX balance_sheet (annual, 2023-12-31) — Net PPE: 16450104.00
DRX.AX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -259682.00
DRX.AX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 63570778.00
DRX.AX balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 67567.00
DRX.AX income_statement (annual, 2023-12-31) — Normalized EBITDA: 10693073.00
DRX.AX income_statement (annual, 2023-12-31) — Normalized Income: 10348964.00
DRX.AX income_statement (annual, 2023-12-31) — Operating Income: -3808296.00
DRX.AX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 3729759126.00
DRX.AX balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 1525313.00
DRX.AX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 1017351.00
DRX.AX income_statement (annual, 2023-12-31) — Other Gand A: 1628015.00
DRX.AX income_statement (annual, 2023-12-31) — Other Income Expense: 13855788.00
DRX.AX balance_sheet (annual, 2023-12-31) — Other Investments: 25000.00
DRX.AX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 22465.00
DRX.AX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 13826533.00
DRX.AX income_statement (annual, 2023-12-31) — Other Operating Expenses: 321221.00
DRX.AX balance_sheet (annual, 2023-12-31) — Other Payable: 730363.00
DRX.AX balance_sheet (annual, 2023-12-31) — Other Properties: 15995529.00
DRX.AX balance_sheet (annual, 2023-12-31) — Other Receivables: 145669.00
DRX.AX balance_sheet (annual, 2023-12-31) — Payables: 1044277.00
DRX.AX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1044277.00
DRX.AX cash_flow (annual, 2023-12-31) — Paymentsto Suppliersfor Goodsand Services: -2645027.00
DRX.AX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 102644.00
DRX.AX income_statement (annual, 2023-12-31) — Pretax Income: 10366209.00
DRX.AX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -9100.00
DRX.AX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -289682.00
DRX.AX cash_flow (annual, 2023-12-31) — Receiptsfrom Customers: 7890.00
DRX.AX balance_sheet (annual, 2023-12-31) — Receivables: 313731.00
DRX.AX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 214220.00
DRX.AX income_statement (annual, 2023-12-31) — Rent And Landing Fees: 22795.00
DRX.AX balance_sheet (annual, 2023-12-31) — Retained Earnings: -31084188.00
DRX.AX income_statement (annual, 2023-12-31) — Salaries And Wages: 1622045.00
DRX.AX cash_flow (annual, 2023-12-31) — Sale Of PPE: 30000.00
DRX.AX income_statement (annual, 2023-12-31) — Selling General And Administration: 3272855.00
DRX.AX balance_sheet (annual, 2023-12-31) — Share Issued: 3729759126.00
DRX.AX income_statement (annual, 2023-12-31) — Special Income Charges: 17245.00
DRX.AX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 63570778.00
DRX.AX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 63570778.00
DRX.AX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
DRX.AX income_statement (annual, 2023-12-31) — Tax Provision: 0.00
DRX.AX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
DRX.AX balance_sheet (annual, 2023-12-31) — Total Assets: 66531895.00
DRX.AX balance_sheet (annual, 2023-12-31) — Total Capitalization: 63570778.00
DRX.AX balance_sheet (annual, 2023-12-31) — Total Debt: 1746629.00
DRX.AX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 63570778.00
DRX.AX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2961117.00
DRX.AX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 55445706.00
DRX.AX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 192926.00
DRX.AX income_statement (annual, 2023-12-31) — Total Unusual Items: 17245.00
DRX.AX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 17245.00
DRX.AX balance_sheet (annual, 2023-12-31) — Working Capital: 8317998.00
DRX.AX income_statement (annual, 2024-12-31) — +Operating Expense: 4279652.00
DRX.AX balance_sheet (annual, 2024-12-31) — Accounts Payable: 351447.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 351447.00
DRX.AX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 93431.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 93431.00
DRX.AX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1086769.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1086769.00
DRX.AX income_statement (annual, 2024-12-31) — Basic Average Shares: 4303460126.00
DRX.AX income_statement (annual, 2024-12-31) — Basic EPS: 0.00
DRX.AX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 10772458.00
DRX.AX cash_flow (annual, 2024-12-31) — Capital Expenditure: -1704748.00
DRX.AX cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -1519012.00
DRX.AX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 187519.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 187519.00
DRX.AX balance_sheet (annual, 2024-12-31) — Capital Stock: 124320539.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Capital Stock: 124320539.00
DRX.AX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 5187296.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 5187296.00
DRX.AX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 5187296.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 5187296.00
DRX.AX balance_sheet (annual, 2024-12-31) — Cash Equivalents: 4000000.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 4000000.00
DRX.AX balance_sheet (annual, 2024-12-31) — Cash Financial: 1187296.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Cash Financial: 1187296.00
DRX.AX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -643794.00
DRX.AX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 1059794.00
DRX.AX cash_flow (annual, 2024-12-31) — Cash Flowsfromusedin Operating Activities Direct: -6001162.00
DRX.AX cash_flow (annual, 2024-12-31) — Changes In Cash: -5585162.00
DRX.AX cash_flow (annual, 2024-12-31) — Classesof Cash Payments: -6555627.00
DRX.AX cash_flow (annual, 2024-12-31) — Classesof Cash Receiptsfrom Operating Activities: 240202.00
DRX.AX balance_sheet (annual, 2024-12-31) — Common Stock: 124320539.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Common Stock: 124320539.00
DRX.AX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 92940360.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 92940360.00
DRX.AX balance_sheet (annual, 2024-12-31) — Current Assets: 5378980.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Current Assets: 5378980.00
DRX.AX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 149709.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 149709.00
DRX.AX balance_sheet (annual, 2024-12-31) — Current Debt: 1016876.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Current Debt: 1016876.00
DRX.AX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1166585.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 1166585.00
DRX.AX balance_sheet (annual, 2024-12-31) — Current Liabilities: 2447798.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 2447798.00
DRX.AX income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 347301.00
DRX.AX income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 347301.00
DRX.AX income_statement (annual, 2024-12-31) — Depreciation Income Statement: 347301.00
DRX.AX income_statement (annual, 2024-12-31) — Diluted Average Shares: 4303460126.00
DRX.AX income_statement (annual, 2024-12-31) — Diluted EPS: 0.00
DRX.AX income_statement (annual, 2024-12-31) — EBIT: -327486.00
DRX.AX income_statement (annual, 2024-12-31) — EBITDA: 19815.00
DRX.AX income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 501370.00
DRX.AX balance_sheet (annual, 2024-12-31) — Employee Benefits: 21945.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Employee Benefits: 21945.00
DRX.AX cash_flow (annual, 2024-12-31) — End Cash Position: 5187296.00
DRX.AX cash_flow (annual, 2024-12-31) — Financing Cash Flow: -643794.00
DRX.AX cash_flow (annual, 2024-12-31) — Free Cash Flow: -7705910.00
DRX.AX income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 6667.00
DRX.AX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 1260752.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 1260752.00
DRX.AX income_statement (annual, 2024-12-31) — General And Administrative Expense: 3536091.00
DRX.AX balance_sheet (annual, 2024-12-31) — Gross PPE: 51593590.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Gross PPE: 51593590.00
DRX.AX income_statement (annual, 2024-12-31) — Interest Expense: 112041.00
DRX.AX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 112041.00
DRX.AX income_statement (annual, 2024-12-31) — Interest Income: 385094.00
DRX.AX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 385094.00
DRX.AX cash_flow (annual, 2024-12-31) — Interest Paid Direct: -120478.00
DRX.AX cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 120478.00
DRX.AX cash_flow (annual, 2024-12-31) — Interest Received Direct: 434741.00
DRX.AX balance_sheet (annual, 2024-12-31) — Invested Capital: 93957236.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Invested Capital: 93957236.00
DRX.AX cash_flow (annual, 2024-12-31) — Investing Cash Flow: 1059794.00
DRX.AX balance_sheet (annual, 2024-12-31) — Investments And Advances: 39544505.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 39544505.00
DRX.AX balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 39449507.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 39449507.00
DRX.AX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 37810.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 37810.00
DRX.AX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 37810.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 37810.00
DRX.AX cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -500000.00
DRX.AX balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 39449507.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 39449507.00
DRX.AX balance_sheet (annual, 2024-12-31) — Long Term Provisions: 4858.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 4858.00
DRX.AX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1596888.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1596888.00
DRX.AX cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 2756360.00
DRX.AX income_statement (annual, 2024-12-31) — Net Income: -439527.00
DRX.AX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -439527.00
DRX.AX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -439527.00
DRX.AX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -439527.00
DRX.AX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -439527.00
DRX.AX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -439527.00
DRX.AX income_statement (annual, 2024-12-31) — Net Interest Income: 273053.00
DRX.AX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -500000.00
DRX.AX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -500000.00
DRX.AX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 273053.00
DRX.AX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -143794.00
DRX.AX balance_sheet (annual, 2024-12-31) — Net PPE: 50506821.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Net PPE: 50506821.00
DRX.AX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -177554.00
DRX.AX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 92940360.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 92940360.00
DRX.AX balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 21945.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 21945.00
DRX.AX income_statement (annual, 2024-12-31) — Normalized EBITDA: 13148.00
DRX.AX income_statement (annual, 2024-12-31) — Normalized Income: -446194.00
DRX.AX income_statement (annual, 2024-12-31) — Operating Income: -4279652.00
DRX.AX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 5008281841.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 5008281841.00
DRX.AX cash_flow (annual, 2024-12-31) — Other Cash Receiptsfrom Operating Activities: 240202.00
DRX.AX balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 1016876.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 1016876.00
DRX.AX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 1260752.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 1260752.00
DRX.AX income_statement (annual, 2024-12-31) — Other Gand A: 1426456.00
DRX.AX income_statement (annual, 2024-12-31) — Other Income Expense: 3567072.00
DRX.AX balance_sheet (annual, 2024-12-31) — Other Investments: 94998.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Other Investments: 94998.00
DRX.AX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 22465.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 22465.00
DRX.AX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 3059035.00
DRX.AX income_statement (annual, 2024-12-31) — Other Operating Expenses: 396260.00
DRX.AX balance_sheet (annual, 2024-12-31) — Other Payable: 737901.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Other Payable: 737901.00
DRX.AX balance_sheet (annual, 2024-12-31) — Other Properties: 49996702.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Other Properties: 49996702.00
DRX.AX balance_sheet (annual, 2024-12-31) — Other Receivables: 98253.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Other Receivables: 98253.00
DRX.AX balance_sheet (annual, 2024-12-31) — Payables: 1089348.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Payables: 1089348.00
DRX.AX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1089348.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 1089348.00
DRX.AX cash_flow (annual, 2024-12-31) — Paymentsto Suppliersfor Goodsand Services: -6555627.00
DRX.AX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 191865.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 191865.00
DRX.AX income_statement (annual, 2024-12-31) — Pretax Income: -439527.00
DRX.AX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -185736.00
DRX.AX balance_sheet (annual, 2024-12-31) — Receivables: 191684.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Receivables: 191684.00
DRX.AX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 347301.00
DRX.AX income_statement (annual, 2024-12-31) — Rent And Landing Fees: 33186.00
DRX.AX cash_flow (annual, 2024-12-31) — Repayment Of Debt: -500000.00
DRX.AX balance_sheet (annual, 2024-12-31) — Retained Earnings: -32640931.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -32640931.00
DRX.AX income_statement (annual, 2024-12-31) — Salaries And Wages: 2076449.00
DRX.AX cash_flow (annual, 2024-12-31) — Sale Of Business: 2756360.00
DRX.AX cash_flow (annual, 2024-12-31) — Sale Of PPE: 8182.00
DRX.AX income_statement (annual, 2024-12-31) — Selling General And Administration: 3536091.00
DRX.AX balance_sheet (annual, 2024-12-31) — Share Issued: 5008281841.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Share Issued: 5008281841.00
DRX.AX income_statement (annual, 2024-12-31) — Special Income Charges: 6667.00
DRX.AX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 92940360.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 92940360.00
DRX.AX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 92940360.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 92940360.00
DRX.AX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
DRX.AX income_statement (annual, 2024-12-31) — Tax Provision: 0.00
DRX.AX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
DRX.AX balance_sheet (annual, 2024-12-31) — Total Assets: 95452771.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Total Assets: 95452771.00
DRX.AX balance_sheet (annual, 2024-12-31) — Total Capitalization: 92940360.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 92940360.00
DRX.AX balance_sheet (annual, 2024-12-31) — Total Debt: 1204395.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Total Debt: 1204395.00
DRX.AX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 92940360.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 92940360.00
DRX.AX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2512411.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 2512411.00
DRX.AX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 90073791.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 90073791.00
DRX.AX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 64613.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 64613.00
DRX.AX income_statement (annual, 2024-12-31) — Total Unusual Items: 6667.00
DRX.AX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 6667.00
DRX.AX balance_sheet (annual, 2024-12-31) — Working Capital: 2931182.00
DRX.AX balance_sheet (quarterly, 2024-12-31) — Working Capital: 2931182.00
DRX.AX income_statement (annual, 2025-12-31) — +Operating Expense: 3305952.00
DRX.AX balance_sheet (annual, 2025-12-31) — Accounts Payable: 278492.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 278492.00
DRX.AX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 165312.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 165312.00
DRX.AX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1087042.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1087042.00
DRX.AX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 5187296.00
DRX.AX cash_flow (annual, 2025-12-31) — Capital Expenditure: -1173713.00
DRX.AX cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -1161708.00
DRX.AX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 37810.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 37810.00
DRX.AX balance_sheet (annual, 2025-12-31) — Capital Stock: 124320539.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 124320539.00
DRX.AX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2338919.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2338919.00
DRX.AX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2338919.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2338919.00
DRX.AX balance_sheet (annual, 2025-12-31) — Cash Equivalents: 1000000.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 1000000.00
DRX.AX balance_sheet (annual, 2025-12-31) — Cash Financial: 1338919.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Cash Financial: 1338919.00
DRX.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 92221.00
DRX.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -549081.00
DRX.AX cash_flow (annual, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: -2391517.00
DRX.AX cash_flow (annual, 2025-12-31) — Changes In Cash: -2848377.00
DRX.AX cash_flow (annual, 2025-12-31) — Classesof Cash Payments: -3000676.00
DRX.AX cash_flow (annual, 2025-12-31) — Classesof Cash Receiptsfrom Operating Activities: 495243.00
DRX.AX balance_sheet (annual, 2025-12-31) — Common Stock: 124320539.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Common Stock: 124320539.00
DRX.AX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 92281659.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 92281659.00
DRX.AX balance_sheet (annual, 2025-12-31) — Current Assets: 2544923.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Current Assets: 2544923.00
DRX.AX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 37810.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 37810.00
DRX.AX balance_sheet (annual, 2025-12-31) — Current Debt: 1016875.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Current Debt: 1016875.00
DRX.AX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1054685.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1054685.00
DRX.AX balance_sheet (annual, 2025-12-31) — Current Liabilities: 2215226.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2215226.00
DRX.AX income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 306602.00
DRX.AX income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 306602.00
DRX.AX income_statement (annual, 2025-12-31) — Depreciation Income Statement: 306602.00
DRX.AX income_statement (annual, 2025-12-31) — EBIT: -659926.00
DRX.AX income_statement (annual, 2025-12-31) — EBITDA: -353324.00
DRX.AX income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 40905.00
DRX.AX balance_sheet (annual, 2025-12-31) — Employee Benefits: 10490.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 10490.00
DRX.AX cash_flow (annual, 2025-12-31) — End Cash Position: 2338919.00
DRX.AX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 92221.00
DRX.AX cash_flow (annual, 2025-12-31) — Free Cash Flow: -3565230.00
DRX.AX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1347006.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1347006.00
DRX.AX income_statement (annual, 2025-12-31) — General And Administrative Expense: 2729174.00
DRX.AX balance_sheet (annual, 2025-12-31) — Gross PPE: 50823693.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 50823693.00
DRX.AX income_statement (annual, 2025-12-31) — Interest Expense: 85029.00
DRX.AX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 85029.00
DRX.AX income_statement (annual, 2025-12-31) — Interest Income: 144429.00
DRX.AX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 144429.00
DRX.AX cash_flow (annual, 2025-12-31) — Interest Paid Direct: -74207.00
DRX.AX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 74207.00
DRX.AX cash_flow (annual, 2025-12-31) — Interest Received Direct: 188123.00
DRX.AX balance_sheet (annual, 2025-12-31) — Invested Capital: 93298534.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 93298534.00
DRX.AX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -549081.00
DRX.AX balance_sheet (annual, 2025-12-31) — Investments And Advances: 42171662.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 42171662.00
DRX.AX balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 39490412.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 39490412.00
DRX.AX balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 39490412.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 39490412.00
DRX.AX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1432777.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1432777.00
DRX.AX income_statement (annual, 2025-12-31) — Net Income: -744955.00
DRX.AX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -744955.00
DRX.AX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -744955.00
DRX.AX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -744955.00
DRX.AX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -744955.00
DRX.AX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -744955.00
DRX.AX cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: 562500.00
DRX.AX income_statement (annual, 2025-12-31) — Net Interest Income: 59400.00
DRX.AX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 59400.00
DRX.AX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 92221.00
DRX.AX cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 51223.00
DRX.AX balance_sheet (annual, 2025-12-31) — Net PPE: 49736651.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Net PPE: 49736651.00
DRX.AX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1096.00
DRX.AX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 92281659.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 92281659.00
DRX.AX balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 10490.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 10490.00
DRX.AX income_statement (annual, 2025-12-31) — Normalized EBITDA: -353324.00
DRX.AX income_statement (annual, 2025-12-31) — Normalized Income: -744955.00
DRX.AX income_statement (annual, 2025-12-31) — Operating Income: -3305952.00
DRX.AX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 5008281841.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 5008281841.00
DRX.AX cash_flow (annual, 2025-12-31) — Other Cash Receiptsfrom Operating Activities: 495243.00
DRX.AX balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 1016875.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 1016875.00
DRX.AX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 1347006.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 1347006.00
DRX.AX income_statement (annual, 2025-12-31) — Other Gand A: 1536195.00
DRX.AX income_statement (annual, 2025-12-31) — Other Income Expense: 2501597.00
DRX.AX balance_sheet (annual, 2025-12-31) — Other Investments: 2681250.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Other Investments: 2681250.00
DRX.AX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 54139.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 54139.00
DRX.AX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 2460692.00
DRX.AX income_statement (annual, 2025-12-31) — Other Operating Expenses: 270176.00
DRX.AX balance_sheet (annual, 2025-12-31) — Other Payable: 661306.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Other Payable: 661306.00
DRX.AX balance_sheet (annual, 2025-12-31) — Other Properties: 49390916.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Other Properties: 49390916.00
DRX.AX balance_sheet (annual, 2025-12-31) — Other Receivables: 40692.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 40692.00
DRX.AX balance_sheet (annual, 2025-12-31) — Payables: 939798.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Payables: 939798.00
DRX.AX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 939798.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 939798.00
DRX.AX cash_flow (annual, 2025-12-31) — Paymentsto Suppliersfor Goodsand Services: -3000676.00
DRX.AX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 220743.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 220743.00
DRX.AX income_statement (annual, 2025-12-31) — Pretax Income: -744955.00
DRX.AX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -12005.00
DRX.AX balance_sheet (annual, 2025-12-31) — Receivables: 206004.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Receivables: 206004.00
DRX.AX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 306602.00
DRX.AX income_statement (annual, 2025-12-31) — Rent And Landing Fees: 23829.00
DRX.AX balance_sheet (annual, 2025-12-31) — Retained Earnings: -33385886.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -33385886.00
DRX.AX income_statement (annual, 2025-12-31) — Salaries And Wages: 1169150.00
DRX.AX cash_flow (annual, 2025-12-31) — Sale Of Intangibles: 562500.00
DRX.AX cash_flow (annual, 2025-12-31) — Sale Of PPE: 10909.00
DRX.AX income_statement (annual, 2025-12-31) — Selling General And Administration: 2729174.00
DRX.AX balance_sheet (annual, 2025-12-31) — Share Issued: 5008281841.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Share Issued: 5008281841.00
DRX.AX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 92281659.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 92281659.00
DRX.AX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 92281659.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 92281659.00
DRX.AX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
DRX.AX income_statement (annual, 2025-12-31) — Tax Provision: 0.00
DRX.AX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
DRX.AX balance_sheet (annual, 2025-12-31) — Total Assets: 94507375.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Total Assets: 94507375.00
DRX.AX balance_sheet (annual, 2025-12-31) — Total Capitalization: 92281659.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 92281659.00
DRX.AX balance_sheet (annual, 2025-12-31) — Total Debt: 1054685.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Total Debt: 1054685.00
DRX.AX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 92281659.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 92281659.00
DRX.AX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2225716.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2225716.00
DRX.AX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 91962452.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 91962452.00
DRX.AX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 10490.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 10490.00
DRX.AX balance_sheet (annual, 2025-12-31) — Working Capital: 329697.00
DRX.AX balance_sheet (quarterly, 2025-12-31) — Working Capital: 329697.00
DRX.L balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 0.00
DRX.L cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -16200000.00
DRX.L income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 24100000.00
DRX.L cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: 0.00
DRX.L balance_sheet (annual, 2021-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 0.00
DRX.L balance_sheet (annual, 2021-12-31) — Other Investments: 5500000.00
DRX.L income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -9400000.00
DRX.L balance_sheet (annual, 2021-12-31) — Other Payable: 366500000.00
DRX.L cash_flow (annual, 2021-12-31) — Pension And Employee Benefit Expense: 3700000.00
DRX.L balance_sheet (annual, 2021-12-31) — Prepaid Assets: 97400000.00
DRX.L cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 0.00
DRX.L balance_sheet (annual, 2021-12-31) — Raw Materials: 54500000.00
DRX.L balance_sheet (annual, 2021-12-31) — Restricted Cash: 172800000.00
DRX.L cash_flow (annual, 2021-12-31) — Sale Of Business: 183700000.00
DRX.L cash_flow (annual, 2021-12-31) — Sale Of Investment: 0.00
DRX.L balance_sheet (annual, 2021-12-31) — Taxes Receivable: 0.00
DRX.L income_statement (annual, 2021-12-31) — Total Other Finance Cost: 6200000.00
DRX.L income_statement (annual, 2022-12-31) — +Operating Expense: 782200000.00
DRX.L income_statement (annual, 2022-12-31) — +Total Revenue: 7775300000.00
DRX.L balance_sheet (annual, 2022-12-31) — Accounts Payable: 152900000.00
DRX.L balance_sheet (annual, 2022-12-31) — Accounts Receivable: 276600000.00
DRX.L balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1923300000.00
DRX.L balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 434800000.00
DRX.L balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -60900000.00
DRX.L income_statement (annual, 2022-12-31) — Amortization: 31400000.00
DRX.L cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 31400000.00
DRX.L income_statement (annual, 2022-12-31) — Basic Average Shares: 400400000.00
DRX.L income_statement (annual, 2022-12-31) — Basic EPS: 0.21
DRX.L cash_flow (annual, 2022-12-31) — Beginning Cash Position: 317400000.00
DRX.L balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 30400000.00
DRX.L cash_flow (annual, 2022-12-31) — Capital Expenditure: -174700000.00
DRX.L balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 153100000.00
DRX.L balance_sheet (annual, 2022-12-31) — Capital Stock: 47900000.00
DRX.L balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 238000000.00
DRX.L balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 238000000.00
DRX.L cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -78900000.00
DRX.L balance_sheet (annual, 2022-12-31) — Cash Equivalents: 135900000.00
DRX.L balance_sheet (annual, 2022-12-31) — Cash Financial: 102100000.00
DRX.L cash_flow (annual, 2022-12-31) — Change In Inventory: -133400000.00
DRX.L cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -293100000.00
DRX.L cash_flow (annual, 2022-12-31) — Change In Payable: 431800000.00
DRX.L cash_flow (annual, 2022-12-31) — Change In Receivables: -379000000.00
DRX.L cash_flow (annual, 2022-12-31) — Change In Working Capital: -402800000.00
DRX.L cash_flow (annual, 2022-12-31) — Changes In Cash: -84900000.00
DRX.L balance_sheet (annual, 2022-12-31) — Common Stock: 47900000.00
DRX.L cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -78900000.00
DRX.L balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1310800000.00
DRX.L cash_flow (annual, 2022-12-31) — Common Stock Issuance: 1200000.00
DRX.L cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
DRX.L balance_sheet (annual, 2022-12-31) — Construction In Progress: 308900000.00
DRX.L income_statement (annual, 2022-12-31) — Cost Of Revenue: 6752000000.00
DRX.L balance_sheet (annual, 2022-12-31) — Current Assets: 2397800000.00
DRX.L balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 22700000.00
DRX.L balance_sheet (annual, 2022-12-31) — Current Debt: 44300000.00
DRX.L balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 67000000.00
DRX.L balance_sheet (annual, 2022-12-31) — Current Liabilities: 2208200000.00
DRX.L cash_flow (annual, 2022-12-31) — Deferred Tax: -9900000.00
DRX.L balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 38500000.00
DRX.L cash_flow (annual, 2022-12-31) — Depreciation: 208000000.00